GOLM1 and Hepatic fibrosis: A systematic review analyzed the sensitivity and specificity of GP73 for liver fibrosis in chronic liver disease as 0.63 (95% CI = 0.60–0.65) and 0.79 (95% CI = 0.76–0.81), respectively, with an AUC of 0.818, although the study did not perform stratified analysis by different liver disease etiologies (41).